The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Pseudomonas aeruginosa Type-3 Secretion System Dampens Host Defense by Exploiting the NLRC4-coupled Inflammasome
Abstract
Rationale: Pseudomonas aeruginosa, a major problem pathogen responsible for severe infections in critically ill patients, triggers, through a functional type-3 secretion system (T3SS), the activation of an intracellular cytosolic sensor of innate immunity, NLRC4. Although the NLRC4-inflammasome–dependent response contributes to increased clearance of intracellular pathogens, it seems that NLRC4 inflammasome activation decreases the clearance of P. aeruginosa, a mainly extracellular pathogen. Objectives: We sought to determine the underlying mechanisms of this effect of the activation of NLRC4 by P. aeruginosa. Methods: We established acute lung injury in wild-type and Nlrc4− / − mice using sublethal intranasal inocula of P. aeruginosa strain CHA expressing or not a functional T3SS. We studied 96-hour survival, lung injury, bacterial clearance from the lungs, cytokine secretion in bronchoalveolar lavage, lung antimicrobial peptide expression by quantitative polymerase chain reaction, and flow cytometry analysis of lung cells. Measurements and Main Results: Nlrc4 − / − mice showed enhanced bacterial clearance and decreased lung injury contributing to increased survival against extracellular P. aeruginosa strain expressing a functional T3SS. The mechanism involved decreased NLRC4-inflammasome–driven IL-18 secretion attenuating lung injury caused by excessive neutrophil recruitment. Additionally, in the lungs of Nlrc4− / − mice secretion of IL-17 by innate immune cells was increased and responsible for increased expression of lung epithelial antimicrobial peptides. Furthermore, IL-18 secretion was found to repress IL-17 and IL-17–driven lung antimicrobial peptide expression. Conclusions: We report a new role of the T3SS apparatus itself, independently of exotoxin translocation. Through NLRC4 inflammasome activation, the T3SS promotes IL-18 secretion, which dampens a beneficial IL-17–mediated antimicrobial host response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“some researches show that inflammasome activation enhances host defense to clear P. aeruginosa,302,303 whereas others present opposite results that inflammasome activation triggered severe host tissue damage, which may impact disease progression and mortality.304,305”
From Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics (2022) · cites this paper as [304]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
The acute respiratory distress syndrome
Matthay, M. A., Ware, L. B., & Zimmerman, G. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60331 · Cited by 1,706
Research works printed but not linked: 42
- Hauser, 2012, Ventilator-associated pneumonia caused by Pseudomonas aeruginosa: cap your needles!, Crit Care Med, 40, 2503, 10.1097/CCM.0b013e318258e5bb · doi:10.1097/ccm.0b013e318258e5bb
- François, 2012, Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: a randomized,double-blind, placebo-controlled trial, Crit Care Med, 40, 2320, 10.1097/CCM.0b013e31825334f6 · DOI · Paper page
- Hauser, 2009, The type III secretion system of Pseudomonas aeruginosa: infection by injection, Nat Rev Microbiol, 7, 654, 10.1038/nrmicro2199 · DOI · Paper page
- Hauser, 2002, Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa, Crit Care Med, 30, 521, 10.1097/00003246-200203000-00005 · DOI · Paper page
- Sawa, 1999, Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury, Nat Med, 5, 392, 10.1038/7391 · DOI · Paper page
- Ader, 2005, Alveolar response to Pseudomonas aeruginosa: role of the type III secretion system, Infect Immun, 73, 4263, 10.1128/IAI.73.7.4263-4271.2005 · DOI
- Miao, 2010, Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome, Proc Natl Acad Sci USA, 107, 3076, 10.1073/pnas.0913087107 · DOI · Paper page
- Vinzing, 2008, NAIP and Ipaf control Legionella pneumophila replication in human cells, J Immunol, 180, 6808, 10.4049/jimmunol.180.10.6808 · DOI
- Sauer, 2011, Listeria monocytogenes engineered to activate the Nlrc4 inflammasome are severely attenuated and are poor inducers of protective immunity, Proc Natl Acad Sci USA, 108, 12419, 10.1073/pnas.1019041108 · DOI
- Brodsky, 2011, Pyroptosis: macrophage suicide exposes hidden invaders, Curr Biol, 21, R72, 10.1016/j.cub.2010.12.008 · DOI
- Arlehamn, 2011, Pseudomonas aeruginosa pilin activates the inflammasome, Cell Microbiol, 13, 388, 10.1111/j.1462-5822.2010.01541.x · DOI
- Cohen, 2013, Activation of inflammasome signaling mediates pathology of acute P. aeruginosa pneumonia, J Clin Invest, 123, 1630, 10.1172/JCI66142 · DOI · Paper page
- Toussaint, 1993, Pseudomonas aeruginosa contains an IHF-like protein that binds to the algD promoter, Biochem Biophys Res Commun, 196, 416, 10.1006/bbrc.1993.2265 · DOI
- Goure, 2004, The V antigen of Pseudomonas aeruginosa is required for assembly of the functional PopB/PopD translocation pore in host cell membranes, Infect Immun, 72, 4741, 10.1128/IAI.72.8.4741-4750.2004 · DOI · Paper page
- Shen, 2008, Orf1/SpcS chaperones ExoS for type three secretion by Pseudomonas aeruginosa, Biomed Environ Sci, 21, 103, 10.1016/S0895-3988(08)60014-8 · DOI
- Eberl, 2004, An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells, Nat Immunol, 5, 64, 10.1038/ni1022 · DOI · Paper page
- Boutoille, 2009, FITC-albumin as a marker for assessment of endothelial permeability in mice: comparison with 125I-albumin, Exp Lung Res, 35, 263, 10.1080/01902140802632290 · DOI
- Bergsbaken, 2011, Coordinated host responses during pyroptosis: caspase-1-dependent lysosome exocytosis and inflammatory cytokine maturation, J Immunol, 187, 2748, 10.4049/jimmunol.1100477 · DOI
- Dubin, 2012, Interleukin-23-mediated inflammation in Pseudomonas aeruginosa pulmonary infection, Infect Immun, 80, 398, 10.1128/IAI.05821-11 · DOI
- Guaní-Guerra, 2010, Antimicrobial peptides: general overview and clinical implications in human health and disease, Clin Immunol, 135, 1, 10.1016/j.clim.2009.12.004 · DOI · Paper page
- Doss, 2010, Human defensins and LL-37 in mucosal immunity, J Leukoc Biol, 87, 79, 10.1189/jlb.0609382 · DOI · Paper page
- Tecle, 2010, Review: Defensins and cathelicidins in lung immunity, Innate Immun, 16, 151, 10.1177/1753425910365734 · DOI · Paper page
- Flannagan, 2009, Antimicrobial mechanisms of phagocytes and bacterial evasion strategies, Nat Rev Microbiol, 7, 355, 10.1038/nrmicro2128 · DOI · Paper page
- Schultz, 2003, Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa, Infect Immun, 71, 1630, 10.1128/IAI.71.4.1630-1634.2003 · DOI
- Qu, 2012, Phosphorylation of NLRC4 is critical for inflammasome activation, Nature, 490, 539, 10.1038/nature11429 · DOI · Paper page
- Labed, 2012, The pseudokinase NIPI-4 is a novel regulator of antimicrobial peptide gene expression, PLoS ONE, 7, e33887, 10.1371/journal.pone.0033887 · DOI
- Nakabayashi, 1990, Phosphorylation of magainin-2 by protein kinase C and inhibition of protein kinase C isozymes by a synthetic analogue of magainin-2-amide, FEBS Lett, 267, 135, 10.1016/0014-5793(90)80307-5 · doi:10.1016/0014-5793(90)80307-5
- Arend, 2008, IL-1, IL-18, and IL-33 families of cytokines, Immunol Rev, 223, 20, 10.1111/j.1600-065X.2008.00624.x · DOI · Paper page
- Sutterwala, 2009, NLRC4/IPAF: a CARD carrying member of the NLR family, Clin Immunol, 130, 2, 10.1016/j.clim.2008.08.011 · DOI
- Mijares, 2011, Airway epithelial MyD88 restores control of Pseudomonas aeruginosa murine infection via an IL-1-dependent pathway, J Immunol, 186, 7080, 10.4049/jimmunol.1003687 · DOI
- Ramphal, 2008, Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin, J Immunol, 181, 586, 10.4049/jimmunol.181.1.586 · DOI
- Xaplanteri, 2009, Synergistic regulation of Pseudomonas aeruginosa-induced cytokine production in human monocytes by mannose receptor and TLR2, Eur J Immunol, 39, 730, 10.1002/eji.200838872 · DOI
- Dolinay, 2012, Inflammasome-regulated cytokines are critical mediators of acute lung injury, Am J Respir Crit Care Med, 185, 1225, 10.1164/rccm.201201-0003OC · DOI · Paper page
- Maeda, 1990, [Role of alveolar macrophages and neutrophils in the defense system against infection of Pseudomonas aeruginosa in the respiratory tract and the effect of derivative of muramyl dipeptide], Nihon Kyobu Shikkan Gakkai Zasshi, 28, 135
- Singh, 2012, Acute lung injury results from failure of neutrophil de-priming: a new hypothesis, Eur J Clin Invest, 42, 1342, 10.1111/j.1365-2362.2012.02720.x · doi:10.1111/j.1365-2362.2012.02720.x
- Balamayooran, 2010, Mechanisms of neutrophil accumulation in the lungs against bacteria, Am J Respir Cell Mol Biol, 43, 5, 10.1165/rcmb.2009-0047TR · DOI · Paper page
- Bhatia, 2012, Role of chemokines in the pathogenesis of acute lung injury, Am J Respir Cell Mol Biol, 46, 566, 10.1165/rcmb.2011-0392TR · DOI · Paper page
- Amulic, 2012, Neutrophil function: from mechanisms to disease, Annu Rev Immunol, 30, 459, 10.1146/annurev-immunol-020711-074942 · DOI · Paper page
- Dubin, 2008, Th17 cytokines and mucosal immunity, Immunol Rev, 226, 160, 10.1111/j.1600-065X.2008.00703.x · DOI · Paper page
- Eddens, 2012, Host defenses against bacterial lower respiratory tract infection, Curr Opin Immunol, 24, 424, 10.1016/j.coi.2012.07.005 · DOI
- Wu, 2012, Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia, Am J Respir Crit Care Med, 186, 420, 10.1164/rccm.201202-0182OC · DOI
- Papp, 2012, Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis, N Engl J Med, 366, 1181, 10.1056/NEJMoa1109017 · DOI · Paper page
Cited by
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
Man, S. M., Karki, R., & Kanneganti, T. (2017) · Immunological Reviews · doi:10.1111/imr.12534 · Cited by 1,657
Regulation of inflammasome activation
Man, S. M., & Kanneganti, T. (2015) · Immunological Reviews · doi:10.1111/imr.12296 · Cited by 1,064
Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors
Jurado-Martín, I., Sainz-Mejías, M., & McClean, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063128 · Cited by 698
Pathogenesis of pneumonia and acute lung injury
Long, M. E., Mallampalli, R. K., & Horowitz, J. C. (2022) · Clinical Science · doi:10.1042/cs20210879 · Cited by 390
Metadata
- Authors
- Faure, E., Mear, J.-B., Faure, K., Normand, S., Couturier-Maillard, A., Grandjean, T., Balloy, V., Ryffel, B., Dessein, R., Chignard, M., Uyttenhove, C., Guery, B., Gosset, P., Chamaillard, M., & Kipnis, E.
- Affiliations
- Pseudomonas aeruginosa Host-Pathogen Translational Research Group, Université Droit et Santé de Lille, Lille, France
- Université Lille Nord de France, Lille, France
- Unité de Défense Innée et Inflammation, Institut Pasteur, Paris, France
- Immunologie et Neurogénétique Expérimentales et Moléculaires, Unité Mixte de Recherche 7355, Orléans, France
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-04-01
- Volume
- 189
- Issue
- 7
- Pages
- 799-811
- ISSN
- 1073-449X
- 1535-4970
- Cited by
- 98
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pseudomonas aeruginosa Type-3 Secretion System Dampens Host Defense by Exploiting the NLRC4-coupled Inflammasome. https://app.cochat.ai/papers/10.1164/rccm.201307-1358oc
- The paper
- Faure, E., Mear, J.-B., Faure, K., Normand, S., Couturier-Maillard, A., Grandjean, T., Balloy, V., Ryffel, B., Dessein, R., Chignard, M., Uyttenhove, C., Guery, B., Gosset, P., Chamaillard, M., & Kipnis, E. (2014). Pseudomonas aeruginosa Type-3 Secretion System Dampens Host Defense by Exploiting the NLRC4-coupled Inflammasome. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201307-1358oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.